Donald Deieso, Ph.D., Chairman & CEO, WIRB-Copernicus Group
Edmundo Muniz, M.D., Ph.D., CEO, Certara
Donald Deieso, Ph.D., of WIRB-Copernicus Group and Edmundo Muniz, M.D., Ph.D., of Certara discuss some of the challenges facing the pharmaceutical industry today; what can be done to enhance the chances of drugs making it to market; and ways to improve patient access, accele … Read More »
Greg Skalicky, Chief Commercial Officer, inVentiv Health
Greg Skalicky of inVentiv Health discusses the various industry dynamics impacting clinical research, as well as why it’s important to marry the clinical and commercial sides of the business together.
Marty Anderson, Executive Director, Clinical Development, INC Research
Marty Anderson of INC Research discusses the unique challenges facing vaccine trials, and how to overcome them.
Brett Kleger, Chief Commercial Officer, DrugDev
Brett Kleger of DrugDev talks about collaboration, standardization, and bringing a beautiful technology experience into clinical research.
Peter Benton, President and COO, Worldwide Clinical Trials
Peter Benton of Worldwide Clinical Trials talks about the challenges facing clinical trial sponsors, where drug and device innovations will come from, and how to attract the best and brightest talent.
Kevin Duffy, Global VP, Life Sciences, KellyOCG
Kevin Duffy of KellyOCG outlines talent engagement obstacles in life-science organizations and the risks companies face by not having an evolving talent strategy.
Kevin Bickford, Senior Director, Clinical Operations, ClinicalRM
Joseph Sgherza, President, ClinicalRM
Kevin Bickford and Joseph Sgherza of ClinicalRM discuss preparing for and responding to global health crises and pandemics, such as Zika and Ebola.
Scott Gray, CEO, Clincierge
Scott Gray of Clincierge discusses how to increase patient engagement in clinical trials, provides learnings from advocacy group surveys, and shares a recent success story on protocol innovations.
Nita Ichhpurani, Senior Director, External Study Management, Drug Development Services, Celerion
Thomas Marbury, President, Orlando Clinical Research Center
Nita Ichhpurani of Celerion and Thomas Marbury of Orlando Clinical Research Center discuss pharmacokinetic studies for patients with renal and hepatic impairment, and how to overcome patient recruitment challenges for this type of clinical research.
Eric Valentine, Global Director, Clinical Distribution Services, Catalent Pharma Solutions
Eric Valentine of Catalent Pharma Solutions provides an overview of the company’s new FastChain demand-led supply model and how it improves the management of global clinical supplies.
Lee Walke, VP eClinical/Real World Evidence, Medpace
Lee Walke of Medpace discusses how eClinical systems are evolving to support risk-based monitoring, how to keep patients engaged, and what it will take to make eSource a reality.
Sy Pretorius, Chief Scientific Officer, PAREXEL
Sy Pretorius of PAREXEL talks about key industry hot topics — adaptive study design personalized medicine patient recruitment, mHealth technology and data, and accelerated pathway approvals — and how PAREXEL is addressing these trends.
Brian Schaechter, Vice President, Clinical Trial Division, Artcraft Health
Brian Schaechter of Artcraft Health shares trends in patient centricity and the impact of patient education on clinical trials.
Patrick Lindsay, President, UBC
Patrick Lindsay of UBC explains why recognizing the important contributions being made by the “heros” in the biopharmaceutical industry who tirelessly fight disease and improve patient lives is so important, and outlines some of the most significant recent achievements in th … Read More »
Sonja VanWye, Director, Clinical Operations Head of Project Management, TKL Research
Sonja VanWye of TKL Research talks about the challenges in creating a successful sponsor/CRO relationship, the benefits of partnering with a CRO instead of maintaining the process in-house, and what capabilities sponsors should look for in a CRO.
Kara Dennis, Managing Director, Mobile Health, Medidata Solutions Worldwide
Kara Dennis of Medidata Solutions Worldwide discusses how mHealth technology, such as wearables, sensors, and apps, are positiviely impacting clinical trials and the benefits of harnessing the new types of data being collected.
John Herzig, Regional Sales Director, Lionbridge Life Sciences
John Herzig of Lionbridge Life Sciences talks about trends in the life sciences, managing today’s greatest challenges, and how technology is helping overcome these challenges.
Jill McGuinn, VP, Biotechnology Strategy, INC Research
Jill McGuinn of INC Research talks about clinical development challenges in biotechnology, strategies to overcome these obstacles, and keys to a successful CRO-biotech partnership.
Jonathan Andrus, Chief Data & Privacy Officer, Clinical Ink
Jonathan Andrus of Clinical Ink talks about improving the clinical trial experience by using eSource, and how the technology is a game changer for data management and monitoring.
Eric Morrie, Director of Product Operations, ClinCapture
Eric Morrie of ClinCapture talks about the evolving eClinical industry, including disruptive solutions in clinical research technology.
Adam Butler, Senior VP, Strategic Development and Corporate Marketing, Bracket
Adam Butler of Bracket talks about using technology to improve patient engagement in clinical trials.
Dr. Martine Dehlinger-Kremer, Global VP and Regulatory Affairs, SynteractHCR
Dr. Martine Dehlinger-Kremer of SynteractHCR discusses the advantages of the new EU clinical trial regulation intended to streamline the clinical trial approval process by simplifying the authorization process, which is set to come into force at the end of 2017, and its rele … Read More »
Matt Kibby, President and Chief Innovation Officer, BBK Worldwide
Thomas Klein, Founder and CEO, Be the Partner
Matt Kibby of BBK Worldwide and Thomas Klein of Be the Partner discuss the new connected mHealth model for increasing patient engagement and other clinical research benefits.
Cheryle Evans, Senior VP, Clinical & Medical Operations, Advanced Clinical
Cheryle Evans of Advanced Clinical discusses designing and implementing a risk-based monitoring program.
Dr. Hendrik Arend Kroon, Chief Medical Officer and Executive VP, Hallux
The California-based pharmaceutical company is developing a new terbinafine dosage form and subungual route of administration for the treatment of onychomycosis (toenail fungus). “We are currently testing in the clinic using the ClinCapture EDC system” explains Hendrik Arend … Read More »
J. Fredrick Pritchard Ph.D., Vice President, Global Drug Development, Celerion
Deborah Chee M.D., Ph.D., President, KoNECT
Drs. Pritchard and Chee discuss Celerion’s expansion into South Korea, KoNECT’s role in fostering clinical research in South Korea, and the advantages of conducting clinical research in South Korea.